GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (HAM:CNW) » Definitions » EPS without NRI

Codon AG (HAM:CNW) EPS without NRI : €-0.53 (TTM As of Jun. 2022)


View and export this data going back to 1990. Start your Free Trial

What is Codon AG EPS without NRI?

Codon AG's earnings per share without non-recurring items for the six months ended in Jun. 2022 was €-0.41. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2022 was €-0.53.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Codon AG's EPS without NRI or its related term are showing as below:

HAM:CNW's 3-Year EPS without NRI Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 5.5
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Codon AG's EPS (Diluted) for the six months ended in Jun. 2022 was €-0.41. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was €-0.53.

Codon AG's EPS (Basic) for the six months ended in Jun. 2022 was €-0.41. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2022 was €-0.53.


Codon AG EPS without NRI Historical Data

The historical data trend for Codon AG's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codon AG EPS without NRI Chart

Codon AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.65 -1.53 -1.26 -1.21 -0.41

Codon AG Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.64 -0.65 -0.14 -0.12 -0.41

Competitive Comparison of Codon AG's EPS without NRI

For the Biotechnology subindustry, Codon AG's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Codon AG's PE Ratio without NRI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Codon AG's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Codon AG's PE Ratio without NRI falls into.



Codon AG EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Codon AG  (HAM:CNW) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Codon AG EPS without NRI Related Terms

Thank you for viewing the detailed overview of Codon AG's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Codon AG (HAM:CNW) Business Description

Traded in Other Exchanges
N/A
Address
Warthestrasse 21, Teltow, DEU, 14513
Codon AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells (autologous chondrocytes). CODON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated.